Healthcare -
Biotechnology - NASDAQ - US
$ 30.91
-1.4 %
$ 2.01 B
Market Cap
-10.37
P/E
KYMR - OPERATING INCOME
Operating Income KYMR - Kymera Therapeutics, Inc.
-166 M
LAST VALUE
-28.32%
2 YEAR CAGR
-50.48%
5 YEAR CAGR
0.00%
10 YEAR CAGR